GALKEM is a LTD company, was created on Dec 2nd 2013 with the main scope of delivery standard NGS services at competitive prices. Competence and reliability focused on the needs of the customer are our main goals. For further information please contact: ceo@galkem.com

GALKEM will operate as an Illumina certified service provider and will mostly work on Illumina 2500 machines. GALKEM staff has outstanding experience in bioinformatics analyses applied to NGS, as proven by the development of dedicated software like FusionAnalyser, CEQer, SpliceFinder. Examples of scientific publications produced thanks for our NGS facility are:

• Blood. 2014 Oct 24. pii: blood-2014-06-579466. [Epub ahead of print]
• J Natl Cancer Inst. 2014 Feb;106(2):djt378. doi: 10.1093/jnci/djt378
• Nature Genetics, 2013 Jan;45(1):18-24)
• Carcinogenesis. 2013 Dec;34(12):2767-73
• Applied Microbiology and Biotechnology 2013, 97: 6561-6570
• ISME J. 2013 Aug;7(8):1483-92
• PLoS One. 2013 Oct 4;8(10):e74825
• Nucleic Acids Res. 2012 Sep;40(16):e123

GALKEM is devoted to develop new TKIS aganist ALK and other oncogenic TK. For further information please contact our drug development team at tki-dev@galkem.com